BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1177255)

  • 1. Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.
    Griggs LJ; Jarman M
    J Med Chem; 1975 Nov; 18(11):1102-6. PubMed ID: 1177255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.
    Struck RF; Kirk MC; Witt MH; Laster WR
    Biomed Mass Spectrom; 1975 Feb; 2(1):46-52. PubMed ID: 1131393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
    Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
    Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systems.
    Ludeman SM; Zon G
    J Med Chem; 1975 Dec; 18(12):1251-3. PubMed ID: 1195278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylating properties of phosphoramide mustard.
    Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
    Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor evaluation of 4-ethoxycarbonyl cyclophosphamide analogs.
    Foster EL
    J Pharm Sci; 1978 May; 67(5):709-10. PubMed ID: 641817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
    Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
    Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.
    Jarman M; Milsted RA; Smyth JF; Kinas RW; Pankiewicz K; Stec WJ
    Cancer Res; 1979 Jul; 39(7 Pt 1):2762-7. PubMed ID: 445480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K; Yamaguchi K
    J Med Chem; 1975 Apr; 18(4):376-83. PubMed ID: 1121004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined thin-layer chromatography-photography-densitometry for the quantitation of cyclophosphamide and its four principal urinary metabolites.
    Hadidi AH; Idle JR
    J Chromatogr; 1988 May; 427(1):121-30. PubMed ID: 3410892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitation of cyclophosphamide in human blood and urine by mass spectrometry-stable isotope dilution.
    Jarman M; Gilby ED; Foster AB; Bondy PK
    Clin Chim Acta; 1975 Jan; 58(1):61-9. PubMed ID: 164304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
    Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
    Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry of nitrosoureas. Decomposition of Deuterated 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Brundrett RB; Cowens JW; Colvin M
    J Med Chem; 1976 Jul; 19(7):958-61. PubMed ID: 940114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and quantitation of alcophosphamide, a metabolite of cyclophosphamide, in the rat using chemical ionization mass spectrometry.
    Hong PS; Chan KK
    Biomed Environ Mass Spectrom; 1987 Apr; 14(4):167-72. PubMed ID: 2954602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new metabolites of phosphoramide and nor-nitrogen mustards and cyclophosphamide in rat urine using ion cluster techniques.
    Chan KK; Hong SC; Watson E; Deng SK
    Biomed Environ Mass Spectrom; 1986 Mar; 13(3):145-54. PubMed ID: 2938656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeled oxazaphosphorines for applications in mass spectrometry studies. 2. Synthesis of deuterium-labeled 2-dechloroethylcyclophosphamides and 2- and 3-dechloroethylifosfamides.
    Springer JB; Colvin OM; Ludeman SM
    J Labelled Comp Radiopharm; 2014 Feb; 57(2):110-4. PubMed ID: 24307455
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.